{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:42Z","timestamp":1786984242791,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Projects Funded by the Natural Science Foundation of Hebei Province in 2022","award":["H2022105014"],"award-info":[{"award-number":["H2022105014"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pituitary neuroendocrine tumors (PitNETs) are commonly managed with endoscopic endonasal transsphenoidal surgery (EETS), but early postoperative hypopituitarism remains a clinically important complication. This retrospective cohort study analyzed early postoperative risk factors for hypopituitarism in 124 patients with PitNETs who underwent EETS at a single center between January 2022 and December 2024. Endocrine status was assessed preoperatively, during the immediate postoperative period before discharge (postoperative days 3\u20137), and at scheduled outpatient reassessments at 1 and 3 months after surgery; the mean interval from surgery to endpoint endocrine assessment was 3.2\u2005\u00b1\u20050.6 months. Patients were categorized into a hypopituitarism group (n\u2005=\u200538) and a non-hypopituitarism group (n\u2005=\u200586) based on postoperative endocrine evaluation across the hypothalamic\u2013pituitary\u2013adrenal, thyroid, gonadal, and growth hormone axes. Demographic, radiologic, perioperative, and endocrine data were collected, and univariate and multivariate logistic regression analyses were performed. Patients who developed hypopituitarism were older and had larger tumors, higher Knosp grades, more frequent suprasellar extension, longer operation times, greater intraoperative blood loss, more intraoperative cerebrospinal fluid leakage, and lower rates of gross total resection. In the multivariate model, maximum tumor diameter (adjusted odds ratio [aOR] per 10-mm increase\u2005=\u20052.02, 95% confidence interval [CI]: 1.09\u20133.74) and Knosp grade 3\u20134 (aOR\u2005=\u20052.37, 95% CI: 1.03\u20135.46) were identified as independent risk factors for early postoperative hypopituitarism, whereas gross total resection was independently associated with a reduced risk (aOR\u2005=\u20050.39, 95% CI: 0.16\u20130.96). These findings indicate that tumor anatomy and extent of resection are key determinants of early endocrine outcomes after EETS and should be incorporated into preoperative risk stratification and postoperative endocrine surveillance; however, they should not be extrapolated to long-term pituitary functional recovery or deterioration without further follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050217","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:02:10Z","timestamp":1786730530000},"page":"e50217","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of early postoperative risk factors for hypopituitarism after endoscopic endonasal transsphenoidal surgery for pituitary neuroendocrine tumors"],"prefix":"10.1097","volume":"105","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tangshan People\u2019s Hospital, Tangshan City, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Gao","sequence":"additional","affiliation":[{"name":"Physical Examination Center, Tangshan People\u2019s Hospital, Tangshan City, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tangshan People\u2019s Hospital, Tangshan City, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Tangshan People\u2019s Hospital, Tangshan City, Hebei Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8900-5784","authenticated-orcid":false,"given":"Xiao Liu","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tangshan People\u2019s Hospital, Tangshan City, Hebei Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"e230021","DOI":"10.1530\/ERC-23-0021","article-title":"The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal.","volume":"30","author":"Villa","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp-2023-209060","article-title":"The road ahead: a brief guide to navigating the 2022 WHO classification of endocrine and neuroendocrine tumours.","volume":"78","author":"Juhlin","year":"2024","journal-title":"J Clin Pathol"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s11604-023-01400-7","article-title":"Imaging of pituitary tumors: an update with the 5th WHO classifications\u2014part 1. Pituitary neuroendocrine tumor (PitNET)\/pituitary adenoma.","volume":"41","author":"Tsukamoto","year":"2023","journal-title":"Jpn J Radiol"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"407","DOI":"10.25259\/SNI_750_2024","article-title":"The learning curve and outcomes of 1038 endoscopic endonasal transsphenoidal pituitary tumor surgeries - a single surgical team experience.","volume":"15","author":"Gurses","year":"2024","journal-title":"Surg Neurol Int"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/j.wneu.2024.02.009","article-title":"Clinical and surgical outcomes of endoscopic endonasal approach for giant pituitary adenomas: analysis of predictive factors.","volume":"184","author":"Eguiluz-Melendez","year":"2024","journal-title":"World Neurosurg"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00701-025-06495-7","article-title":"Complications following endoscopic transsphenoidal surgery for pituitary adenoma-special focus on intrasellar pressure.","volume":"167","author":"Simander","year":"2025","journal-title":"Acta Neurochir (Wien)"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"101901","DOI":"10.1016\/j.inat.2023.101901","article-title":"Transsphenoid surgery outcomes in pituitary adenoma patients at Sumatera Utara University Hospital in 2022\u20132023: a prospective study.","volume":"36","author":"Nasution","year":"2024","journal-title":"Interdiscip Neurosurg"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.wneu.2024.07.095","article-title":"Postoperative hyponatremia after endoscopic endonasal resection of pituitary adenomas: historical complication rates and risk factors.","volume":"190","author":"Snyder","year":"2024","journal-title":"World Neurosurg"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.3390\/jcm14186656","article-title":"Risk-stratifying pituitary adenoma treatment: a cohort analysis and risk prediction of hypopituitarism.","volume":"14","author":"Agha","year":"2025","journal-title":"J Clin Med"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"21607","DOI":"10.1038\/s41598-024-72944-5","article-title":"Risk factor analysis and prediction model to establish recurrence or progression of non-functioning pituitary adenomas in men after transnasal sphenoidal surgery.","volume":"14","author":"Zhong","year":"2024","journal-title":"Sci Rep"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"837025","DOI":"10.3389\/fendo.2022.837025","article-title":"Outcome of endoscopic transsphenoidal surgery for recurrent or residual pituitary adenomas and comparison to non-recurrent or residual cohort by propensity score analysis.","volume":"13","author":"Gong","year":"2022","journal-title":"Front Endocrinol"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3171\/2024.8.JNS232715","article-title":"Association between pituitary adenoma consistency, resection techniques, and patient outcomes: a single-institution experience.","volume":"142","author":"Guerra","year":"2025","journal-title":"J Neurosurg"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11102-024-01495-9","article-title":"Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade.","volume":"28","author":"Fiore","year":"2025","journal-title":"Pituitary"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"19226","DOI":"10.1038\/s41598-025-03053-0","article-title":"Long-term pituitary function following transsphenoidal surgery for non-functional pituitary neuroendocrine tumor with apoplexy: a single-center retrospective analysis.","volume":"15","author":"Zou","year":"2025","journal-title":"Sci Rep"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"433","DOI":"10.25259\/SNI_642_2022","article-title":"Determinants of visual and endocrinological outcome after early endoscopic endonasal surgery for pituitary apoplexy.","volume":"13","author":"Galal","year":"2022","journal-title":"Surg Neurol Int"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12902-021-00777-8","article-title":"Post-operative volumes following endoscopic surgery for non-functioning pituitary macroadenomas are predictive of further intervention, but not endocrine outcomes.","volume":"21","author":"Seejore","year":"2021","journal-title":"BMC Endocrine Disord"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/neurolint17010005","article-title":"Endocrine outcome and quality of life after transsphenoidal resection of pituitary adenoma\u2014a prospective randomized single-blinded study comparing endoscopic versus microscopic resection.","volume":"17","author":"Pala","year":"2025","journal-title":"Neurol Int"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3803\/EnM.2023.1838","article-title":"Update on current evidence for the diagnosis and management of nonfunctioning pituitary neuroendocrine tumors.","volume":"38","author":"Whyte","year":"2023","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:12Z","timestamp":1786982472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":18,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050217","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2025-12-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}